International Edition
Latest News
Health

University of Utah Researchers Characterize Protein Protecting Spinal Discs from Aging

On Oct. 9, University of Utah researchers announced the first functional characterization of a little-known protein that helps protect spinal discs from age-related damage. The findings point to a potential direction for future treatments targeting back pain, which…

University of Utah Researchers Characterize Protein Protecting Spinal Discs from Aging

On Oct. 9, University of Utah researchers announced the first functional characterization of a little-known protein that helps protect spinal discs from age-related damage.

The findings point to a potential direction for future treatments targeting back pain, which ranks as the third leading cause of disability globally behind cardiac disease and drug use disorders, as reported by News-Medical.

The interdisciplinary team used the gene-editing tool CRISPR to target ZNF865, also known as BLST, in human cells as well as mouse and rat models. The study found that levels of BLST were lower in older and damaged spinal discs, which are the cushionlike structures between vertebrae that allow the spine to move.

Restoring BLST production in human disc cells reduced signs of cellular aging and DNA damage, according to the study published in Aging Cell. Conversely, reducing BLST activity in rodents led to disc degeneration and pain-related behaviors.

“This paper directly shows a novel understanding that DNA damage is a driver of back pain, and that we can regulate BLST therapeutically with CRISPR,” said Robby D. Bowles, associate professor of biomedical engineering at the University of Utah.

Research team and collaborations

The National Institute of Arthritis and Musculoskeletal and Skin Diseases funded the work, which involved investigators from the University of Utah’s Huntsman Cancer Institute, orthopaedics and arthritis experts at the Spencer Fox Eccles School of Medicine, and Bowles along with his lab team in the John and Marcia Price College of Engineering.

University of Utah Researchers Characterize Protein Protecting Spinal Discs from Aging
Photo: miragenews.com

Coauthors on the study include Christian Lewis, Hunter Levis, Jonah Holbrook, and Molly Czachor from the Bowles Pain & Engineered Therapeutics Lab.

Additional coauthors include Jacob T. Polaski of Huntsman Cancer Institute, Josh Mizels and Brandon Lawrence of the Department of Orthopaedics, Sarah E. Gullbrand of the University of Pennsylvania, and Timothy D. Jacobsen alongside James C. Iatridis of the Department of Orthopaedics at the Icahn School of Medicine at Mount Sinai, as well as Brian Diekman from the University of North Carolina at Chapel Hill, as reported by Mirage News.

“It has been the highlight of my career to work on a protein that was unknown and be the first to identify its function,” Bowles told News-Medical.

Implications for cancer and future trials

Beyond back pain, researchers note that the mechanisms identified in the study could inform investigations into DNA damage associated with cancer and neurodegeneration. BLST is widely expressed across various tissues, suggesting broader therapeutic potential.

“The fact that a single gene can restore normal cell function and reverse aging-related effects is incredible,” said Jason Gertz, who serves as a co-leader of the Genomics, Epigenetics, and Metabolism Program at Huntsman Cancer Institute and is a professor in the Department of Oncological Sciences.

“BLST is widely expressed across tissues and could be a promising target for cancer treatment and prevention, since boosting BLST activity should improve the repair of DNA damage and the overall health of aging cells.”

Additional preclinical studies and eventual clinical trials are required to determine whether targeting BLST with CRISPR is safe and effective in humans, and whether the same mechanisms drive age-related cancers.

Frequently asked questions about BLST research

What specific gene does BLST refer to?

BLST refers to ZNF865, a gene and protein whose functional characteristics were recently identified for the first time by University of Utah researchers.

How was BLST tested in the study?

Researchers used the gene-editing tool CRISPR to increase and decrease BLST levels in human disc cells as well as in mouse and rat models.

What funding supported the study?

The work was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

“While this work focuses on its application to back pain, the mechanisms identified have the potential to be applied to treat cancer, neurodegeneration, and any disease in which DNA damage is involved,” Bowles told News-Medical.

About the author: Health Desk

Health Desk at Archynewsy.